Mirabegron CAS: 223673-61-8 Chaw tsim tshuaj paus
Mirabegron yog ib qho active β3-adrenoceptor agonist tam sim no nyob rau hauv txoj kev loj hlob los ntawm Astellas Pharma rau kev kho mob ntawm overactive zais zis (OAB).Cov tshuaj yog ib tug nanomolar EC50 antagonist tawm tsam tib neeg β3-AR biochemical kev soj ntsuam nrog zoo xaiv tshaj b1- thiab β2-ARs.Mirabegron qhia txog lub tswv yim tshiab los ntawm kev tsom mus rau β3-AR rau lub zais zis los pab tswj OAB cov tsos mob xws li nce zis ceev thiab zaus thiab ceev ceev incontinence.Txawm li cas los xij, mirabegron yog cytochrome P450 2D6 inhibitor, thiab nws ua rau muaj kev txhawj xeeb rau kev siv tshuaj yeeb-tshuaj nrog kev tswj hwm ntawm lwm cov cytochrome P450 2D6 substrates.
Kev sib xyaw | C21H24N4O2S |
Assay | 99% |
Qhov tshwm sim | Dawb rau Pale Yellow hmoov |
CAS Nr. | 223673-61-8 |
Ntim | 25 KG |
Txee lub neej | 2 xyoo |
Cia | Khaws rau hauv qhov chaw txias thiab qhuav |
Daim ntawv pov thawj | ISO. |
Sau koj cov lus ntawm no thiab xa tuaj rau peb